secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bolt Biotherapeutics, Inc. (BOLT)
CIK:        0001641281
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0000950170-25-001159
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bolt Biotherapeutics transfers to Nasdaq Capital Market to extend bid price compliance deadline to June 30, 2025
--------------------------------------------------------------------------------

- Transfer approved Jan 2, 2025; effective at market open Jan 6, 2025.
- Company failed to regain $1 minimum bid price by original Dec 30, 2024 deadline.
- Additional compliance period until June 30, 2025; must close at $1+ for 10 consecutive business days.
- Bolt may effect a reverse stock split to cure the deficiency if needed.
- Failure to regain compliance by June 30 could lead to delisting and a potential Nasdaq appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641281/000095017025001159/0000950170-25-001159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641281/000095017025001159/bolt-20250102.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-001159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer